New critique proposes TRCS aging model
A recently shared peer‑reviewed critique argues that standard aging theories are incomplete and proposes a TRCS model as a better foundation for intervention research. The author linked a feasibility analysis supporting their new framework in a post on April 14. (x.com/BiluHuang/status/2043642608329842989)
Aging research usually starts from a checklist of biological changes, but a new peer-reviewed critique says that checklist misses the main driver and points researchers to a different model. (sciltp.com) The paper, “Feasibility Analysis of Mainstream Aging Theories and Intervention,” was published April 13, 2026, in *Aging and Longevity Research* as an open-access perspective by Bilu Huang. It argues that several standard theories — including epigenetic, free-radical, mitochondrial, somatic-mutation, autophagy, and inflammation models — are “fundamentally flawed.” (sciltp.com) Huang instead centers the Telomere DNA and Ribosomal DNA Co-regulation Model for Cell Senescence, or TRCS. In plain terms, the model says cells age because two repeated DNA systems — telomeres at chromosome ends and ribosomal DNA arrays that help make ribosomes — deteriorate together and trigger growth arrest. (sciltp.com) That claim cuts against the framework many labs use now. The 2013 “hallmarks of aging” paper listed nine major processes, and the 2023 update expanded that list to 12, keeping aging as a multi-cause process rather than a single upstream program. (pmc.ncbi.nlm.nih.gov, cell.com) Telomeres are already part of mainstream aging biology. Reviews in recent years have described telomere attrition as both a hallmark and a driver of aging, while also stressing that it interacts with other processes rather than explaining aging by itself. (pmc.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov) The newer piece of Huang’s argument is ribosomal DNA, or ribosomal gene repeats, which are less central in standard aging models. A 2024 bioRxiv preprint by Huang and Zhengzhi Wu reported that partial knockout of 45S ribosomal DNA increased aging markers and reduced cell passage times, which the authors said was preliminary support for co-regulation with telomeres. (biorxiv.org) The April 2026 critique goes further than that preprint. It says interventions tied to mainstream theories, including senescent-cell clearance and young-plasma infusion, have not produced major lifespan extension and in some reports have accelerated aging, so the field should reassess the theory behind those bets. (sciltp.com) Huang has been advancing versions of this idea for several years. His Google Scholar page lists a 2021 TRCS paper, a 2025 *Aging and Disease* article on “Causality of Aging Hallmarks,” and multiple 2025 working papers extending the model into disease and intervention claims. (scholar.google.com) The paper’s publication does not mean the field has adopted the model. The broad review literature still describes aging as complex, multi-level, and not fully settled, with calls for integrative approaches rather than one accepted master mechanism. (pmc.ncbi.nlm.nih.gov, pmc.ncbi.nlm.nih.gov) What happens next is less about rhetoric than replication. If other groups can show that changing telomeres and ribosomal DNA together predicts or reverses cell aging better than today’s frameworks, TRCS moves from critique to testable foundation. (biorxiv.org, sciltp.com)
